Inspire Investing LLC Has $2.29 Million Stake in Chemed Corporation $CHE

Key Points

• Inspire Investing LLC reduced its stake in Chemed Corporation by 31.4%, selling 1,700 shares and now holding 3,721 shares valued at approximately $2.29 million.
• Chemed's quarterly earnings were $4.27 per share, missing estimates and showing a 3.8% increase in quarterly revenue compared to the previous year.
• The company announced an increase in its quarterly dividend from $0.50 to $0.60 per share, reflecting a positive change in its financial policy.

Inspire Investing LLC reduced its holdings in Chemed Corporation (NYSE:CHE - Free Report) by 31.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,721 shares of the company's stock after selling 1,700 shares during the period. Inspire Investing LLC's holdings in Chemed were worth $2,290,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Baird Financial Group Inc. increased its holdings in shares of Chemed by 6.1% in the 4th quarter. Baird Financial Group Inc. now owns 1,352 shares of the company's stock valued at $716,000 after purchasing an additional 78 shares during the period. Jefferies Financial Group Inc. grew its position in Chemed by 335.0% during the fourth quarter. Jefferies Financial Group Inc. now owns 1,453 shares of the company's stock valued at $770,000 after purchasing an additional 1,119 shares in the last quarter. Lazard Asset Management LLC grew its position in Chemed by 245.4% during the fourth quarter. Lazard Asset Management LLC now owns 10,166 shares of the company's stock valued at $5,385,000 after purchasing an additional 7,223 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Chemed by 16.8% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 3,358 shares of the company's stock valued at $1,779,000 after buying an additional 482 shares during the period. Finally, Nuveen Asset Management LLC lifted its position in Chemed by 18.0% in the 4th quarter. Nuveen Asset Management LLC now owns 39,451 shares of the company's stock worth $20,901,000 after buying an additional 6,005 shares in the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Chemed

In other news, Director George J. Walsh III acquired 200 shares of the firm's stock in a transaction that occurred on Monday, August 4th. The stock was acquired at an average cost of $417.10 per share, with a total value of $83,420.00. Following the acquisition, the director owned 3,523 shares in the company, valued at approximately $1,469,443.30. This represents a 6.02% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Nicholas Michael Westfall sold 10,012 shares of the firm's stock in a transaction on Monday, August 4th. The shares were sold at an average price of $421.91, for a total transaction of $4,224,162.92. The disclosure for this sale can be found here. 3.29% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

CHE has been the topic of several research analyst reports. Wall Street Zen cut shares of Chemed from a "buy" rating to a "hold" rating in a report on Saturday, July 5th. Jefferies Financial Group upgraded Chemed from a "hold" rating to a "buy" rating and boosted their target price for the company from $490.00 to $550.00 in a research note on Tuesday, September 2nd. Bank of America dropped their target price on Chemed from $610.00 to $595.00 and set a "buy" rating on the stock in a research report on Wednesday, September 10th. Oppenheimer reduced their price target on Chemed from $650.00 to $580.00 and set an "outperform" rating for the company in a report on Thursday, July 31st. Finally, Royal Bank Of Canada dropped their price objective on Chemed from $640.00 to $589.00 and set an "outperform" rating on the stock in a report on Thursday, July 31st. Four research analysts have rated the stock with a Buy rating, According to MarketBeat, Chemed presently has an average rating of "Buy" and an average target price of $578.50.

Chemed Trading Up 2.0%

NYSE CHE traded up $9.12 during trading on Wednesday, hitting $456.75. 82,271 shares of the company traded hands, compared to its average volume of 142,432. Chemed Corporation has a 12 month low of $408.42 and a 12 month high of $623.60. The business has a fifty day simple moving average of $451.07 and a 200 day simple moving average of $528.87. The company has a market capitalization of $6.65 billion, a P/E ratio of 23.48, a PEG ratio of 2.57 and a beta of 0.46.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The company reported $4.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $6.02 by ($1.75). Chemed had a return on equity of 25.83% and a net margin of 11.56%.The company had revenue of $618.80 million for the quarter, compared to the consensus estimate of $650.60 million. During the same quarter last year, the company posted $5.47 EPS. The business's revenue was up 3.8% compared to the same quarter last year. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. Equities research analysts predict that Chemed Corporation will post 21.43 EPS for the current fiscal year.

Chemed Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, August 29th. Stockholders of record on Monday, August 11th were given a $0.60 dividend. This is a positive change from Chemed's previous quarterly dividend of $0.50. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend was Monday, August 11th. Chemed's payout ratio is 12.34%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.